An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin

AH Barnett, M Dreyer, Peter Lange, M Serdarevic-Pehar

    56 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin'. Together they form a unique fingerprint.

    Medicine & Life Sciences